Publications by authors named "Angela J Tsuang"
The SunBEAm birth cohort: Protocol design.
J Allergy Clin Immunol Glob
August 2023
Article Synopsis
- Food allergies (FA) and atopic dermatitis (AD) often appear in infants, making it crucial to understand their causes for better prevention and treatment strategies.
- The SunBEAm birth cohort, funded by NIAID, is a multi-center study in the US that follows pregnant couples and their newborns, aiming to enroll 2,500 infants to explore environmental and biological factors influencing FA and AD.
- The cohort will collect a diverse range of samples and data, allowing researchers to examine the mechanisms behind early allergic reactions, focusing specifically on common allergens like egg, milk, and peanut.
Successful baked egg and baked milk oral immunotherapy in a pediatric cohort.
J Allergy Clin Immunol Pract
February 2023
Purpose: We assess for frequency and predictive factors related to sustained intraocular pressure (IOP) elevation in eyes with neovascular age-related macular degeneration receiving intravitreal injections of ranibizumab and/or bevacizumab.
Methods: A total of 328 patients with neovascular age-related macular degeneration (449 eyes) who presented to a single physician over a 6-month period were retrospectively assessed for baseline demographic/clinical information, total number of bevacizumab and/or ranibizumab injections, and sustained IOP elevation on 2 or more consecutive visits (absolute IOP >25 mmHg, increase above baseline >10 mmHg, or IOP of >21 mmHg and increase of >5 mmHg). Cox regression survival analysis and multivariate logistic regression were performed to assess the influence of intravitreal injections on experiencing sustained IOP elevation.
Purpose: We assessed the frequency and predictive factors related to intraocular pressure (IOP) elevation in neovascular age-related macular degeneration (AMD) patients undergoing unilateral intravitreal ranibizumab and/or bevacizumab injections.
Design: Retrospective cohort study.
Participants: Charts of 207 patients with neovascular AMD who presented to a single physician at a retinal referral practice over a 6-month period were retrospectively reviewed.